A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer

Chih Cheng Chien, Chun Chao Chang, Shung Haur Yang, Shu Hung Chen, Chi Jung Huang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The altered expression of certain genes is frequently detected as a hallmark of malignant tumors. These differentially expressed genes have the potential to become molecular markers. We purified the fecal mRNA from patients with colorectal cancer to identify novel candidates by using oligonucleotide microarray hybridization. We identified 21 upregulated and 22 downregulated candidates with significantly altered expression in patient fecal samples that have not been previously characterized. A gene encoding a homologue of the Drosophila headcase protein (HECA) was further examined due to its high ranking and possible importance in some human cancers. A tendency towards increased expression of HECA was dependent upon the clinicopathological stage. In this report, healthy individuals expressed less HECA, either in their blood samples or feces. Moreover, we detected upregulated HECA in blood and fecal samples of patients with colorectal cancer, and its expression level was shown to be significantly correlated with disease status. Our data show that HECA may be an early-stage classifier of colorectal cancer that can discriminate between late- and early-stage disease. In conclusion, this study is the first to analyze differentially expressed genes in the feces of colorectal cancer patients using oligonucleotide microarrays. The data suggest that HECA expression levels in feces may be an effective classifier for early-stage colorectal cancer.

Original languageEnglish
Pages (from-to)919-926
Number of pages8
JournalOncology Reports
Volume15
Issue number4
Publication statusPublished - Apr 2006

Fingerprint

Tumor Biomarkers
Colorectal Neoplasms
Feces
Oligonucleotide Array Sequence Analysis
Proteins
Genes
Blood Proteins
Neoplasms
Down-Regulation
Drosophila headcase protein
Gene Expression
Messenger RNA

Keywords

  • Colorectal cancer
  • Fecal differential expressed genes
  • Homologue of the Drosophila headcase protein
  • Oligonucleotide microarray
  • Stage classifier

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer. / Chien, Chih Cheng; Chang, Chun Chao; Yang, Shung Haur; Chen, Shu Hung; Huang, Chi Jung.

In: Oncology Reports, Vol. 15, No. 4, 04.2006, p. 919-926.

Research output: Contribution to journalArticle

Chien, Chih Cheng ; Chang, Chun Chao ; Yang, Shung Haur ; Chen, Shu Hung ; Huang, Chi Jung. / A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer. In: Oncology Reports. 2006 ; Vol. 15, No. 4. pp. 919-926.
@article{ed48140c6b1b40049cee077038e6a8b5,
title = "A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer",
abstract = "The altered expression of certain genes is frequently detected as a hallmark of malignant tumors. These differentially expressed genes have the potential to become molecular markers. We purified the fecal mRNA from patients with colorectal cancer to identify novel candidates by using oligonucleotide microarray hybridization. We identified 21 upregulated and 22 downregulated candidates with significantly altered expression in patient fecal samples that have not been previously characterized. A gene encoding a homologue of the Drosophila headcase protein (HECA) was further examined due to its high ranking and possible importance in some human cancers. A tendency towards increased expression of HECA was dependent upon the clinicopathological stage. In this report, healthy individuals expressed less HECA, either in their blood samples or feces. Moreover, we detected upregulated HECA in blood and fecal samples of patients with colorectal cancer, and its expression level was shown to be significantly correlated with disease status. Our data show that HECA may be an early-stage classifier of colorectal cancer that can discriminate between late- and early-stage disease. In conclusion, this study is the first to analyze differentially expressed genes in the feces of colorectal cancer patients using oligonucleotide microarrays. The data suggest that HECA expression levels in feces may be an effective classifier for early-stage colorectal cancer.",
keywords = "Colorectal cancer, Fecal differential expressed genes, Homologue of the Drosophila headcase protein, Oligonucleotide microarray, Stage classifier",
author = "Chien, {Chih Cheng} and Chang, {Chun Chao} and Yang, {Shung Haur} and Chen, {Shu Hung} and Huang, {Chi Jung}",
year = "2006",
month = "4",
language = "English",
volume = "15",
pages = "919--926",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer

AU - Chien, Chih Cheng

AU - Chang, Chun Chao

AU - Yang, Shung Haur

AU - Chen, Shu Hung

AU - Huang, Chi Jung

PY - 2006/4

Y1 - 2006/4

N2 - The altered expression of certain genes is frequently detected as a hallmark of malignant tumors. These differentially expressed genes have the potential to become molecular markers. We purified the fecal mRNA from patients with colorectal cancer to identify novel candidates by using oligonucleotide microarray hybridization. We identified 21 upregulated and 22 downregulated candidates with significantly altered expression in patient fecal samples that have not been previously characterized. A gene encoding a homologue of the Drosophila headcase protein (HECA) was further examined due to its high ranking and possible importance in some human cancers. A tendency towards increased expression of HECA was dependent upon the clinicopathological stage. In this report, healthy individuals expressed less HECA, either in their blood samples or feces. Moreover, we detected upregulated HECA in blood and fecal samples of patients with colorectal cancer, and its expression level was shown to be significantly correlated with disease status. Our data show that HECA may be an early-stage classifier of colorectal cancer that can discriminate between late- and early-stage disease. In conclusion, this study is the first to analyze differentially expressed genes in the feces of colorectal cancer patients using oligonucleotide microarrays. The data suggest that HECA expression levels in feces may be an effective classifier for early-stage colorectal cancer.

AB - The altered expression of certain genes is frequently detected as a hallmark of malignant tumors. These differentially expressed genes have the potential to become molecular markers. We purified the fecal mRNA from patients with colorectal cancer to identify novel candidates by using oligonucleotide microarray hybridization. We identified 21 upregulated and 22 downregulated candidates with significantly altered expression in patient fecal samples that have not been previously characterized. A gene encoding a homologue of the Drosophila headcase protein (HECA) was further examined due to its high ranking and possible importance in some human cancers. A tendency towards increased expression of HECA was dependent upon the clinicopathological stage. In this report, healthy individuals expressed less HECA, either in their blood samples or feces. Moreover, we detected upregulated HECA in blood and fecal samples of patients with colorectal cancer, and its expression level was shown to be significantly correlated with disease status. Our data show that HECA may be an early-stage classifier of colorectal cancer that can discriminate between late- and early-stage disease. In conclusion, this study is the first to analyze differentially expressed genes in the feces of colorectal cancer patients using oligonucleotide microarrays. The data suggest that HECA expression levels in feces may be an effective classifier for early-stage colorectal cancer.

KW - Colorectal cancer

KW - Fecal differential expressed genes

KW - Homologue of the Drosophila headcase protein

KW - Oligonucleotide microarray

KW - Stage classifier

UR - http://www.scopus.com/inward/record.url?scp=33746412078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746412078&partnerID=8YFLogxK

M3 - Article

C2 - 16525680

AN - SCOPUS:33746412078

VL - 15

SP - 919

EP - 926

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -